这是一篇来自已证抗体库的有关人类 细胞周期蛋白D2 (cyclin D2) 的综述,是根据23篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合细胞周期蛋白D2 抗体。
细胞周期蛋白D2 同义词: KIAK0002; MPPH3

圣克鲁斯生物技术
小鼠 单克隆(B-6)
  • 免疫印迹; 大鼠; 图 5a
圣克鲁斯生物技术细胞周期蛋白D2抗体(Santa Cruz Biotechnology, sc-376676)被用于被用于免疫印迹在大鼠样本上 (图 5a). J Cell Biol (2021) ncbi
小鼠 单克隆(B-6)
圣克鲁斯生物技术细胞周期蛋白D2抗体(Santa Cruz Biotechnology, sc-376676)被用于. Protein Expr Purif (2021) ncbi
小鼠 单克隆(DCS-5)
  • 流式细胞仪; 人类; 图 6
圣克鲁斯生物技术细胞周期蛋白D2抗体(Santa Cruz, sc-53637)被用于被用于流式细胞仪在人类样本上 (图 6). Melanoma Res (2015) ncbi
大鼠 单克隆(34B1-3)
  • 免疫印迹; 人类
圣克鲁斯生物技术细胞周期蛋白D2抗体(Santa Cruz, sc-452)被用于被用于免疫印迹在人类样本上. Oncotarget (2015) ncbi
小鼠 单克隆(A-1)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术细胞周期蛋白D2抗体(Santa Cruz, sc- 166288)被用于被用于免疫印迹在小鼠样本上. Mol Cell Biol (2014) ncbi
赛默飞世尔
小鼠 单克隆(DCS-3.1)
  • 免疫印迹; 大鼠
赛默飞世尔细胞周期蛋白D2抗体(Biosource International, DCS-3.1)被用于被用于免疫印迹在大鼠样本上. Exp Cell Res (2006) ncbi
小鼠 单克隆(DCS3.1)
  • 免疫印迹; 大鼠
赛默飞世尔细胞周期蛋白D2抗体(Biosource International, DCS-3.1)被用于被用于免疫印迹在大鼠样本上. Exp Cell Res (2006) ncbi
小鼠 单克隆(DCS-3.1)
  • 免疫印迹; 大鼠; 图 8
赛默飞世尔细胞周期蛋白D2抗体(BioSource, AHF0112)被用于被用于免疫印迹在大鼠样本上 (图 8). Mol Endocrinol (2003) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D52F9)
  • 免疫印迹; 小鼠; 1:1000; 图 5h
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(CST, 37413)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5h). elife (2022) ncbi
domestic rabbit 单克隆(D52F9)
  • 免疫印迹; 人类; 图 3e
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(Cell Signal, 3741)被用于被用于免疫印迹在人类样本上 (图 3e). Clin Transl Med (2021) ncbi
domestic rabbit 单克隆(D52F9)
  • 免疫印迹; 小鼠; 图 4b
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(Cell Signaling, D52F9)被用于被用于免疫印迹在小鼠样本上 (图 4b). PLoS ONE (2020) ncbi
domestic rabbit 单克隆(D52F9)
  • 免疫组化; 小鼠; 图 5f
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(Cell Signaling, 3741)被用于被用于免疫组化在小鼠样本上 (图 5f). J Clin Invest (2020) ncbi
domestic rabbit 单克隆(D52F9)
  • 免疫印迹; 人类; 图 1e
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(CST, 3741)被用于被用于免疫印迹在人类样本上 (图 1e). Cell Rep (2019) ncbi
domestic rabbit 单克隆(D52F9)
  • 免疫印迹基因敲除验证; 小鼠; 图 2a
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(Cell Signaling, 3741)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 2a). Nature (2018) ncbi
domestic rabbit 单克隆(D52F9)
  • 免疫印迹; 人类; 1:1000; 图 4c
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(cell signalling, 3741)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4c). Int J Oncol (2017) ncbi
domestic rabbit 单克隆(D52F9)
  • 免疫印迹; 人类; 图 2c
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(Cell Signaling, 3741)被用于被用于免疫印迹在人类样本上 (图 2c). J Biol Chem (2017) ncbi
domestic rabbit 单克隆(D52F9)
  • 免疫印迹; 人类; 图 s3
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(Cell Signaling Tech, 3741)被用于被用于免疫印迹在人类样本上 (图 s3). Sci Rep (2016) ncbi
domestic rabbit 单克隆(D52F9)
  • 免疫印迹; 人类; 1:1000; 图 3b
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(Cell Signaling, 3741)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3b). Cell Death Dis (2016) ncbi
domestic rabbit 单克隆(D52F9)
  • 免疫印迹; 人类; 1:2000; 图 3
  • 免疫印迹; 小鼠; 1:2000; 图 2
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(Cell Signaling, D52F9)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 3) 和 被用于免疫印迹在小鼠样本上浓度为1:2000 (图 2). J Proteome Res (2016) ncbi
domestic rabbit 单克隆(D52F9)
  • 免疫印迹; 人类; 1:1000; 图 5
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(Cell Signaling Technology, D52F9)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5). Int J Mol Med (2016) ncbi
domestic rabbit 单克隆(D52F9)
  • 免疫印迹; 小鼠; 1:500; 图 s4
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(Cell signaling, 3741)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 s4). J Bone Miner Res (2016) ncbi
domestic rabbit 单克隆(D52F9)
  • 免疫印迹; 人类; 1:1000; 图 5d
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(Cell Signaling, 3741)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5d). Mol Med Rep (2016) ncbi
domestic rabbit 单克隆(D52F9)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司细胞周期蛋白D2抗体(Cell Signaling Technology, 3741)被用于被用于免疫印迹在小鼠样本上. J Neurosci (2013) ncbi
碧迪BD
小鼠 单克隆(G132-43)
  • 其他; 人类; 图 st1
碧迪BD细胞周期蛋白D2抗体(BD, G132-43)被用于被用于其他在人类样本上 (图 st1). Mol Cell Proteomics (2016) ncbi
文章列表
  1. Kennedy L, Glesaaen E, Palibrk V, Pannone M, Wang W, Al Jabri A, et al. Lactate receptor HCAR1 regulates neurogenesis and microglia activation after neonatal hypoxia-ischemia. elife. 2022;11: pubmed 出版商
  2. Zhang Y, He L, Huang L, Yao S, Lin N, Li P, et al. Oncogenic PAX6 elicits CDK4/6 inhibitor resistance by epigenetically inactivating the LATS2-Hippo signaling pathway. Clin Transl Med. 2021;11:e503 pubmed 出版商
  3. Song L, Tian X, Schekman R. Extracellular vesicles from neurons promote neural induction of stem cells through cyclin D1. J Cell Biol. 2021;220: pubmed 出版商
  4. Chen A, Santana A, Doudican N, Roudiani N, Laursen K, Therrien J, et al. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. PLoS ONE. 2020;15:e0241551 pubmed 出版商
  5. Abdel Aziz M, Fan Y, Liu L, Moasser M, Fu H, Jura N, et al. Expression and purification of active human kinases using Pichia pastoris as a general-purpose host. Protein Expr Purif. 2021;179:105780 pubmed 出版商
  6. Muller A, Dickmanns A, Resch C, Schakel K, Hailfinger S, Dobbelstein M, et al. The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. J Clin Invest. 2020;: pubmed 出版商
  7. Cornell L, Wander S, Visal T, Wagle N, Shapiro G. MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance. Cell Rep. 2019;26:2667-2680.e7 pubmed 出版商
  8. Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira N, et al. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature. 2018;553:91-95 pubmed 出版商
  9. Li X, Liu F, Lin B, Luo H, Liu M, Wu J, et al. miR?150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma. Int J Oncol. 2017;: pubmed 出版商
  10. Juhasz A, Markel S, Gaur S, Liu H, Lu J, Jiang G, et al. NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction. J Biol Chem. 2017;292:7866-7887 pubmed 出版商
  11. Jeong O, Chae Y, Jung H, Park S, Cho S, Kook H, et al. Long noncoding RNA linc00598 regulates CCND2 transcription and modulates the G1 checkpoint. Sci Rep. 2016;6:32172 pubmed 出版商
  12. Hanna J, Garcia M, Go J, Finkelstein D, Kodali K, Pagala V, et al. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma. Cell Death Dis. 2016;7:e2256 pubmed 出版商
  13. Heaven M, Flint D, Randall S, Sosunov A, Wilson L, Barnes S, et al. Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease. J Proteome Res. 2016;15:2265-82 pubmed 出版商
  14. Zeng Q, Tao X, Huang F, Wu T, Wang J, Jiang X, et al. Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2. Int J Mol Med. 2016;37:1274-80 pubmed 出版商
  15. Xu C, Ochi H, Fukuda T, Sato S, Sunamura S, Takarada T, et al. Circadian Clock Regulates Bone Resorption in Mice. J Bone Miner Res. 2016;31:1344-55 pubmed 出版商
  16. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  17. Mo X, Cao Q, Liang H, Liu J, Li H, Liu F. MicroRNA-610 suppresses the proliferation of human glioblastoma cells by repressing CCND2 and AKT3. Mol Med Rep. 2016;13:1961-6 pubmed 出版商
  18. Sarojini S, Pecora A, Milinovikj N, Barbiere J, Gupta S, Hussain Z, et al. A combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes. Melanoma Res. 2015;25:376-89 pubmed 出版商
  19. Pulvino M, Chen L, Oleksyn D, Li J, Compitello G, Rossi R, et al. Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline. Oncotarget. 2015;6:14796-813 pubmed
  20. Perry M, Dufour C, Eichner L, Tsang D, Deblois G, Muller W, et al. ERBB2 deficiency alters an E2F-1-dependent adaptive stress response and leads to cardiac dysfunction. Mol Cell Biol. 2014;34:4232-43 pubmed 出版商
  21. Crowther A, Gama V, Bevilacqua A, Chang S, Yuan H, Deshmukh M, et al. Tonic activation of Bax primes neural progenitors for rapid apoptosis through a mechanism preserved in medulloblastoma. J Neurosci. 2013;33:18098-108 pubmed 出版商
  22. Fritz M, Mirnics Z, Nylander K, Schor N. p75NTR enhances PC12 cell tumor growth by a non-receptor mechanism involving downregulation of cyclin D2. Exp Cell Res. 2006;312:3287-97 pubmed
  23. Cheng G, Lewis A, Meinkoth J. Ras stimulates aberrant cell cycle progression and apoptosis in rat thyroid cells. Mol Endocrinol. 2003;17:450-9 pubmed